Advanced Closed-Loop Control System Improves Postprandial Glycemic Control Compared With a Hybrid Closed-Loop System Following Unannounced Meal.

Autor: Garcia-Tirado J; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Diaz JL; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Esquivel-Zuniga R; Department of Pediatrics, University of Virginia, Charlottesville, VA., Koravi CLK; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Corbett JP; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Dawson M; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Wakeman C; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Barnett CL; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Oliveri MC; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Myers H; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., Krauthause K, Breton MD; Center for Diabetes Technology, University of Virginia, Charlottesville, VA., DeBoer MD; Center for Diabetes Technology, University of Virginia, Charlottesville, VA deboer@virginia.edu.; Department of Pediatrics, University of Virginia, Charlottesville, VA.
Jazyk: angličtina
Zdroj: Diabetes care [Diabetes Care] 2021 Aug 15. Date of Electronic Publication: 2021 Aug 15.
DOI: 10.2337/dc21-0932
Abstrakt: Objective: Meals are a major hurdle to glycemic control in type 1 diabetes (T1D). Our objective was to test a fully automated closed-loop control (CLC) system in the absence of announcement of carbohydrate ingestion among adolescents with T1D, who are known to commonly omit meal announcement.
Research Design and Methods: Eighteen adolescents with T1D (age 15.6 ± 1.7 years; HbA 1c 7.4 ± 1.5%; 9 females/9 males) participated in a randomized crossover clinical trial comparing our legacy hybrid CLC system (Unified Safety System Virginia [USS]-Virginia) with a novel fully automated CLC system (RocketAP) during two 46-h supervised admissions (each with one announced and one unannounced dinner), following 2 weeks of data collection. Primary outcome was the percentage time-in-range 70-180 mg/dL (TIR) following the unannounced meal, with secondary outcomes related to additional continuous glucose monitoring-based metrics.
Results: Both TIR and time-in-tight-range 70-140 mg/dL (TTR) were significantly higher using RocketAP than using USS-Virginia during the 6 h following the unannounced meal (83% [interquartile range 64-93] vs. 53% [40-71]; P = 0.004 and 49% [41-59] vs. 27% [22-36]; P = 0.002, respectively), primarily driven by reduced time-above-range (TAR >180 mg/dL: 17% [1.3-34] vs. 47% [28-60]), with no increase in time-below-range (TBR <70 mg/dL: 0% median for both). RocketAP also improved control following the announced meal (mean difference TBR: -0.7%, TIR: +7%, TTR: +6%), overall (TIR: +5%, TAR: -5%, TTR: +8%), and overnight (TIR: +7%, TTR: +19%, TAR: -5%). RocketAP delivered less insulin overall (78 ± 23 units vs. 85 ± 20 units, P = 0.01).
Conclusions: A new fully automated CLC system with automatic prandial dosing was proven to be safe and feasible and outperformed our legacy USS-Virginia in an adolescent population with and without meal announcement.
(© 2021 by the American Diabetes Association.)
Databáze: MEDLINE
Externí odkaz: